insights_auto
Outlook: 59.1% bullish·13.6% bearish
Go to analysischevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
$80.85
arrow_upward
+0.92%(+0.74) 1D
$81.22
arrow_upward
+0.46% (+0.37)bedtimeAfter hours
Closed: Oct 7, 4:00:00โฏPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
$78.91
High
$82.22
Low
$78.00
Mkt. cap
7.13B
Avg. vol.
1.43M
Volume
2.72M
52-wk high
$110.18
52-wk low
$16.04
EPS
-$2.32
Beta
3.10
Shares outstanding
88.17M
No. of employees
125
Open
$78.91
High
$82.22
Low
$78.00
Mkt. cap
7.13B
Avg. vol.
1.43M
Volume
2.72M
52-wk high
$110.18
52-wk low
$16.04
EPS
-$2.32
Beta
3.10
Shares outstanding
88.17M
No. of employees
125
News stories
From web sources and news partners
Minichart
·
7 hours ago
Spyre Therapeutics Prices $350 Million Public Offering at $85.00 per Share
TipRanks
·
8 hours ago
Spyre Therapeutics Announces Major Equity Financing Agreement
TradingView
·
9 hours ago
Spyre Therapeutics Launches $350 Million Stock Offering Underwritten by Jefferies, TD, Leerink, Stifel
marketscreener.com
·
1 day ago
Spyre Shares Fall After Pricing $350 Million Stock Offering
About Spyre Therapeutics Inc
CEO-
Employees125
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitespyre.com